On patient-centric treatment decisions and the value of quantitative methodologies, in conversation with Marc Buyse

Patients
pharmaphorum podcast Episode 189a, Marc Buyse

In today's healthcare landscape, there is a pressing need for quantitative methodologies that include the patients' perspective in any treatment decision.

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, about his recent work as one of the editors of โ€“ and a chapter contributor to โ€“ the first edition of "๐˜๐˜ข๐˜ฏ๐˜ฅ๐˜ฃ๐˜ฐ๐˜ฐ๐˜ฌ ๐˜ฐ๐˜ง ๐˜Ž๐˜ฆ๐˜ฏ๐˜ฆ๐˜ณ๐˜ข๐˜ญ๐˜ช๐˜ป๐˜ฆ๐˜ฅ ๐˜—๐˜ข๐˜ช๐˜ณ๐˜ธ๐˜ช๐˜ด๐˜ฆ ๐˜Š๐˜ฐ๐˜ฎ๐˜ฑ๐˜ข๐˜ณ๐˜ช๐˜ด๐˜ฐ๐˜ฏ๐˜ด: ๐˜”๐˜ฆ๐˜ต๐˜ฉ๐˜ฐ๐˜ฅ๐˜ด ๐˜ง๐˜ฐ๐˜ณ ๐˜—๐˜ข๐˜ต๐˜ช๐˜ฆ๐˜ฏ๐˜ต-๐˜Š๐˜ฆ๐˜ฏ๐˜ต๐˜ณ๐˜ช๐˜ค ๐˜ˆ๐˜ฏ๐˜ข๐˜ญ๐˜บ๐˜ด๐˜ช๐˜ด", recently published by the Routledge Taylor & Francis Group.

The conversation explores generalised pairwise comparisons (or GPCs), applications in various disease areas, implications for regulatory approvals and benefit-risk analyses, and considerations for patient centricity in clinical research and treatment decisions.

You can also listen to episode 189a of theโ€ฏpharmaphorum podcastโ€ฏin the player below, download the episode to your computer, or find it - and subscribe to the rest of the series โ€“ on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.